Literature DB >> 9358942

Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities.

P Picci1, L Sangiorgi, L Bahamonde, P Aluigi, J Bibiloni, M Zavatta, M Mercuri, A Briccoli, M Campanacci.   

Abstract

BACKGROUND: Improvements in preoperative staging as well as in chemotherapeutic regimens have made limb-salvage surgery a reliable modality of treatment for high-grade osteosarcomas of the extremities, with local recurrences in most series of less than 10% after this type of surgery. The quality of surgical margins and local response to preoperative chemotherapy are known to be the most significant factors in recurrence [1, 8-10, 12], and complications related to the biopsy procedure may also be a significant factor. The study reported here comprised a histopathological analysis of our recurrent cases as part of an effort to identify the impact of each of the factors cited above.
MATERIALS AND METHODS: Five hundred fourteen cases of high-grade, non-multicentric osteosarcoma of the extremities were treated at the Istituto Ortopedico Rizzoli between March 1983 and August 1991. In this study we analyzed 23 cases of local recurrence in patients with classic osteosarcoma who underwent limb-salvage procedures.
RESULTS: In 15 cases we found correlation between the site of local recurrence and the site where the margins were less than wide. In five cases the recurrence was secondary to complications of the biopsy procedure (hematoma, delayed healing). In one case we suspect a previously undetected skip lesion. In the remaining two cases no clear explanation was found for the recurrence. There was also a statistically significant difference in the time of appearance of recurrences related to the tumor response to chemotherapy.
CONCLUSIONS: For only two cases of recurrence was there no clear explanation. In one we suspect an undetected skip metastasis, and in the other there were certain factors which may have increased its risk of recurrence (non diagnostic trochar biopsy followed by an incisional biopsy, fair tumor necrosis, recurrence in a 'problem' anatomical site, i.e., the popliteal space). In the remaining cases the following factors were found to be directly related to the development of a local recurrence: a) the quality of the surgical margins, b) site of the biopsy as well as complications related to the biopsy procedure, c) local response to preoperative chemotherapy.

Entities:  

Mesh:

Year:  1997        PMID: 9358942     DOI: 10.1023/a:1008230801849

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  19 in total

1.  Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.

Authors:  Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Jung Moon Oh; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2011-10-19       Impact factor: 4.176

2.  What are the factors that affect survival and relapse after local recurrence of osteosarcoma?

Authors:  Akihiko Takeuchi; Valerae O Lewis; Robert L Satcher; Bryan S Moon; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2014-07-01       Impact factor: 4.176

3.  Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma.

Authors:  Amos H P Loh; Huiyun Wu; Armita Bahrami; Fariba Navid; M Beth McCarville; Chong Wang; Jianrong Wu; Michael W Bishop; Najat C Daw; Michael D Neel; Bhaskar N Rao
Journal:  Pediatr Blood Cancer       Date:  2014-11-08       Impact factor: 3.167

4.  Curative-intent radiotherapy for pediatric osteosarcoma: The St. Jude experience.

Authors:  Christopher L Tinkle; Jason Lu; Yuanyuan Han; Yimei Li; Beth M McCarville; Michael D Neel; Michael W Bishop; Matthew J Krasin
Journal:  Pediatr Blood Cancer       Date:  2019-04-22       Impact factor: 3.167

5.  Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions.

Authors:  David Boyce-Fappiano; Ethan P Damron; Ahsan Farooqi; Devarati Mitra; Anthony P Conley; Neeta Somaiah; Dejka M Araujo; J Andrew Livingston; Ravin Ratan; Emily Z Keung; Christina L Roland; B Ashleigh Guadagnolo; Andrew J Bishop
Journal:  Adv Radiat Oncol       Date:  2022-02-05

Review 6.  The multidisciplinary management of osteosarcoma.

Authors:  Noah Federman; Nicholas Bernthal; Fritz C Eilber; William D Tap
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

7.  Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group.

Authors:  Carol D Morris; Lisa A Teot; Mark L Bernstein; Neyssa Marina; Mark D Krailo; Doojduen Villaluna; Katherine A Janeway; Steven G DuBois; Richard G Gorlick; Robert Lor Randall
Journal:  J Surg Oncol       Date:  2016-01-18       Impact factor: 3.454

8.  Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).

Authors:  Barry P Pereira; Yefang Zhou; Anurag Gupta; David T Leong; Khin Zarchi Aung; Ling Ling; Robert W H Pho; Mario Galindo; Manuel Salto-Tellez; Gary S Stein; Simon M Cool; Andre J van Wijnen; Saminathan S Nathan
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

9.  The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma.

Authors:  James R Barnett; Panagiotis Gikas; Craig Gerrand; Tim Wr Briggs; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2020-01-04       Impact factor: 2.199

10.  Current therapeutic strategies and novel approaches in osteosarcoma.

Authors:  Kosei Ando; Marie-Françoise Heymann; Verena Stresing; Kanji Mori; Françoise Rédini; Dominique Heymann
Journal:  Cancers (Basel)       Date:  2013-05-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.